Financial Year |
March 31 2023 |
Monetary Funds |
311,770,286.74 |
Held-for-trading Financial Assets |
564,000,000.00 |
Notes Receivable |
13,012,899.55 |
Accounts Receivable |
463,660,647.71 |
Advances to Suppliers |
10,296,974.47 |
Other Receivables |
5,772,023.17 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
199,615,239.80 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
13,747,172.13 |
Total Current Assets |
1,587,802,456.97 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
209,224,743.73 |
Investment Properties |
25,888,360.70 |
Fixed Assetes |
674,196,231.48 |
Under-construction Projects |
324,791,714.03 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
282,756,108.73 |
R&D expenses |
-- |
Goodwill |
17,812,208.99 |
Long-Term Deferred and Prepaid Expenses |
-- |
Deferred Income Tax Assets |
25,090,725.42 |
Other Non-Current Assets |
86,690,850.67 |
Sub-Total of Non-Current Assets |
1,795,172,092.11 |
Total Assets |
3,382,974,549.08 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
33,370,947.50 |
Accounts Payable |
101,777,615.99 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
25,385,321.91 |
Taxes Payable |
21,487,371.60 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
281,650,947.90 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
18,593.72 |
Other Current Liabilities |
926,325.62 |
Sub-Total of Current Liabilities |
480,272,528.85 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
24,640,822.07 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
38,742,813.69 |
Total Liabilities |
519,015,342.54 |
Paid-In Capital(Or Share Stock) |
352,916,573.00 |
Capital Surplus |
1,328,653,678.14 |
Surplus Reserve |
172,010,008.21 |
LESS:Treasury Stock |
133,545,761.22 |
Undistributed Profits |
1,143,924,708.41 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,863,959,206.54 |
Owner's Equity(Stockholder's Equity) |
2,863,959,206.54 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
3,382,974,549.08 |